↓ Skip to main content

Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study

Overview of attention for article published in BMC Nephrology, February 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study
Published in
BMC Nephrology, February 2013
DOI 10.1186/1471-2369-14-39
Pubmed ID
Authors

Abeer Yasin, Daisy Liu, Luan Chau, Joaquín Madrenas, Guido Filler

Abstract

Fibroblast growth factor-23 (FGF-23), a novel marker of bone disease in chronic kidney disease (CKD) has been shown to correlate with vascular calcifications. We aimed to describe the effect of the calcium phosphate product (Ca*P) on FGF-23 concentrations in children and young adults without confounding cardiovascular disease.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 57 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 18%
Student > Bachelor 9 16%
Student > Master 5 9%
Unspecified 4 7%
Student > Ph. D. Student 4 7%
Other 11 19%
Unknown 14 25%
Readers by discipline Count As %
Medicine and Dentistry 24 42%
Nursing and Health Professions 8 14%
Unspecified 4 7%
Agricultural and Biological Sciences 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 2 4%
Unknown 15 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2013.
All research outputs
#18,329,207
of 22,696,971 outputs
Outputs from BMC Nephrology
#1,859
of 2,453 outputs
Outputs of similar age
#145,595
of 191,530 outputs
Outputs of similar age from BMC Nephrology
#28
of 41 outputs
Altmetric has tracked 22,696,971 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,453 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,530 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.